Cure8 research brief
The paper links specific gut bacteria, inflammatory cytokines, and two microRNAs with UC activity, which could point toward new diagnostic biomarkers or targets for research into disease mechanisms.
Researchers studying IBD pathogenesis or biomarkers; clinicians interested in emerging diagnostic markers for ulcerative colitis; translational scientists working on microbiome–immune interactions.
Researchers compared healthy controls, UC patients in remission, and UC patients with active disease, measuring cultured gut bacteria, serum cytokines by ELISA, and miRNA levels by RT-qPCR.
They report lower counts of Bifidobacterium and Lactobacillus and lower IL-10 and miR-515-5p with increasing disease activity, while Enterobacteriaceae, Enterococcus, IL-6, TNF-α, and miR-330-3p increased.
The authors found statistical associations implying miR-515-5p, Bifidobacterium, Lactobacillus, and IL-10 were linked with lower UC risk, whereas miR-330-3p, Enterobacteriaceae, Enterococcus, IL-6, and TNF-α were associated with higher risk. They evaluated diagnostic value with ROC curves and used multivariate logistic regression to identify risk factors.
Reported findings are from a case-control clinical study using culture-based microbiology and measurements from blood and stool; associations do not establish causality and require independent replication and broader microbiome methods.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Non-invasive fecal lipid markers could help differentiate UC from CD and improve diagnostic molecular profiling in IBD if validated, which may be useful for patients and clinicians seeking less-invasive diagnostic tools.
The study shows that fecal (luminal) and mucosal microbiome and metabolite profiles capture different aspects of pediatric IBD—activity versus phenotype—so combined sampling may give a fuller picture for research and...
Microbial amino-acid metabolites may be active players in IBD biology and could become useful biomarkers or therapeutic targets. Understanding these metabolites helps explain links between the microbiome, immune...
